BKT:BMEBankinter SA Analysis
Data as of 2026-05-31 - not real-time
$10.55
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The share price sits just above the 20‑day moving average but remains under the 50‑day and 200‑day averages, signaling a modest short‑term lift within a prevailing bearish framework. Momentum indicators are mixed: the RSI hovers around the midpoint, while the MACD line has edged above its signal, offering a tentative bullish signal. Trading volume has been on the rise, reinforcing the technical bounce toward the nearest resistance zone. However, the stock’s high dividend yield is offset by a payout ratio that exceeds earnings, raising questions about dividend sustainability. Valuation metrics tell a split story: the price‑to‑earnings multiple is well below the sector average and the price‑to‑book ratio sits under one, suggesting relative cheapness, yet the discounted cash‑flow model points to a considerably lower intrinsic value. With a low beta and moderate 30‑day volatility, price swings are muted, but the fund’s negative operating cash flow and substantial debt add a layer of financial risk.
In the near term, the technical setup offers limited upside potential, but fundamental concerns around cash generation and dividend coverage dominate the outlook. Over the medium horizon, the discrepancy between market price and DCF valuation may pressure the stock lower, especially if dividend cuts materialize. Long‑term investors may find some appeal in the low‑beta exposure and asset‑backed portfolio, but must weigh the ongoing credit and liquidity considerations. Overall, the balance of technical signals and fundamental red flags suggests a cautious stance.
In the near term, the technical setup offers limited upside potential, but fundamental concerns around cash generation and dividend coverage dominate the outlook. Over the medium horizon, the discrepancy between market price and DCF valuation may pressure the stock lower, especially if dividend cuts materialize. Long‑term investors may find some appeal in the low‑beta exposure and asset‑backed portfolio, but must weigh the ongoing credit and liquidity considerations. Overall, the balance of technical signals and fundamental red flags suggests a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price marginally above short‑term moving average with increasing volume
- Mixed technical signals (RSI neutral, MACD bullish crossover)
- High dividend yield but payout ratio above earnings
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair value substantially below current price
- Negative operating cash flow and elevated debt levels
- Potential dividend reduction due to unsustainable payout
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Low beta indicating limited systematic risk
- Price below book value offering a margin of safety
- Asset‑backed portfolio with diversified credit exposure
Key Metrics & Analysis
Financial Health
Revenue Growth-33.60%
Profit Margin203.10%
P/E Ratio11.1
ROE7.94%
ROA1.29%
Debt/Equity22.93
P/B Ratio0.9
Op. Cash Flow$-72030544
Free Cash Flow$24.9M
Industry P/E16.6
Technical Analysis
TrendBearish
RSI50.4
Support$10.21
Resistance$10.72
MA 20$10.52
MA 50$10.61
MA 200$11.06
MACDBullish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$7.55
GradeFair
TypeValue
Dividend Yield10.03%
Risk Assessment
Beta0.21
Volatility10.96%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.